Aegis Life: Funding, Investors & Team (Sep 2026)
Aegis Life is a biotechnology company that has over twenty years of research and development experience in gene delivery. They utilize their nucleic acid delivery technology, fusogenix PLV, to speed up the advancement of vaccines and treatments for infectious diseases in both the research and clinical manufacturing stages.
Aegis Life has raised $4.5M across 2 funding rounds on record, the most recent an undisclosed round of $4.5M announced in Mar 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aegis Life Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Aegis Life Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Aegis Life announced an undisclosed round in Jun 2023; the amount was not disclosed.
9 months later, an undisclosed round of $4.5M was announced in Mar 2024.
Aegis Life Founders and Leadership Team
No contact details are on record for this team yet.
Aegis Life Funding Compared to Other Biotechnology Startups
Aegis Life's latest round of $4.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aegis Life in Biotechnology and San Diego
Companies Similar to Aegis Life
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Aegis Life Funding FAQs
What does Aegis Life do?
Aegis Life is a biotechnology company that has over twenty years of research and development experience in gene delivery. They utilize their nucleic acid delivery technology, fusogenix PLV, to speed up the advancement of vaccines and treatments for infectious diseases in both the research and clinical manufacturing stages.
How much funding has Aegis Life raised?
Aegis Life has raised $4.5M across 2 rounds on record. The most recent is an undisclosed round of $4.5M announced in Mar 2024.
When did Aegis Life last raise funding?
Aegis Life's most recent funding round on record is an undisclosed round of $4.5M, announced in Mar 2024.
Who founded Aegis Life?
FundedIQ lists Greg Logsdon (Founder) at Aegis Life.
Where is Aegis Life headquartered?
Aegis Life is based in San Diego, California, United States.
How many employees does Aegis Life have?
Aegis Life is in the 11-50 employee band.
How does Aegis Life's funding compare to other Biotechnology startups?
Aegis Life's latest round of $4.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aegis Life Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aegis Life is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.